ReviewJournal of mid-life health

Sclerostin Inhibition: A Novel Target for the Treatment of Postmenopausal Osteoporosis.

Suruchi Aditya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.